galenIQ™ is metabolized almost without the need of insulin. Levels of blood glucose and insulin do hardly change from baseline when galenIQ™ containing dosage forms are ingested, making it an highly suitable excipient in formulations for all patient target groups , even for individuals with disorder of carbohydrate metabolism.